Cargando…
Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622912/ https://www.ncbi.nlm.nih.gov/pubmed/26512192 http://dx.doi.org/10.5021/ad.2015.27.5.641 |
| _version_ | 1782397627444232192 |
|---|---|
| author | Lee, Min Kyung Kwon, Won Joo Cho, Eun Byul Park, Eun Joo Kim, Kwang Ho Kim, Kwang Joong |
| author_facet | Lee, Min Kyung Kwon, Won Joo Cho, Eun Byul Park, Eun Joo Kim, Kwang Ho Kim, Kwang Joong |
| author_sort | Lee, Min Kyung |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4622912 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Korean Dermatological Association; The Korean Society for Investigative Dermatology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46229122015-10-28 Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib Lee, Min Kyung Kwon, Won Joo Cho, Eun Byul Park, Eun Joo Kim, Kwang Ho Kim, Kwang Joong Ann Dermatol Letter to the Editor Korean Dermatological Association; The Korean Society for Investigative Dermatology 2015-10 2015-10-02 /pmc/articles/PMC4622912/ /pubmed/26512192 http://dx.doi.org/10.5021/ad.2015.27.5.641 Text en Copyright © 2015 The Korean Dermatological Association and The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Lee, Min Kyung Kwon, Won Joo Cho, Eun Byul Park, Eun Joo Kim, Kwang Ho Kim, Kwang Joong Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib |
| title | Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib |
| title_full | Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib |
| title_fullStr | Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib |
| title_full_unstemmed | Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib |
| title_short | Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib |
| title_sort | imatinib mesylate-induced erythema multiforme: recurrence after rechallenge with 200 mg/day imatinib |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622912/ https://www.ncbi.nlm.nih.gov/pubmed/26512192 http://dx.doi.org/10.5021/ad.2015.27.5.641 |
| work_keys_str_mv | AT leeminkyung imatinibmesylateinducederythemamultiformerecurrenceafterrechallengewith200mgdayimatinib AT kwonwonjoo imatinibmesylateinducederythemamultiformerecurrenceafterrechallengewith200mgdayimatinib AT choeunbyul imatinibmesylateinducederythemamultiformerecurrenceafterrechallengewith200mgdayimatinib AT parkeunjoo imatinibmesylateinducederythemamultiformerecurrenceafterrechallengewith200mgdayimatinib AT kimkwangho imatinibmesylateinducederythemamultiformerecurrenceafterrechallengewith200mgdayimatinib AT kimkwangjoong imatinibmesylateinducederythemamultiformerecurrenceafterrechallengewith200mgdayimatinib |